Clinical Trial Update: KN5501 Cell Injection for Refractory SLE(CLEAR) [Phase 1]

View source ↗

Summary

Phase 1 trial update for KN5501 cell injection in refractory systemic lupus erythematosus (SLE) by Ruitherapeutics Co., Ltd. The study is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• KN5501 Cell Injection

Snippet

Sponsor: Ruitherapeutics Co., LTD | Conditions: Systemic Lupus Erthematosus (SLE) | Phase 1 | Status: NOT_YET_RECRUITING